BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 11289799)

  • 1. Living in oblivion: HIV immune evasion.
    Piguet V; Trono D
    Semin Immunol; 2001 Feb; 13(1):51-7. PubMed ID: 11289799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-HIV adaptive immunity: determinants for viral persistence.
    Yamamoto H; Matano T
    Rev Med Virol; 2008; 18(5):293-303. PubMed ID: 18416450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and molecular interactions in HIV infections: a review.
    Tumbo-Oeri AG; Omwandho CA
    East Afr Med J; 2002 May; 79(5):249-53. PubMed ID: 12638808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity.
    Kent SJ; Fernandez CS; Dale CJ; Davenport MP
    Trends Microbiol; 2005 Jun; 13(6):243-6. PubMed ID: 15936652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nef alleles from children with non-progressive HIV-1 infection modulate MHC-II expression more efficiently than those from rapid progressors.
    Schindler M; Wildum S; Casartelli N; Doria M; Kirchhoff F
    AIDS; 2007 May; 21(9):1103-7. PubMed ID: 17502720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dendritic cell-based vaccine for treating HIV infection: background and preliminary results.
    Andrieu JM; Lu W
    J Intern Med; 2007 Feb; 261(2):123-31. PubMed ID: 17241177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunopathogenesis and immunotherapy in AIDS virus infections.
    Letvin NL; Walker BD
    Nat Med; 2003 Jul; 9(7):861-6. PubMed ID: 12835706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary sooty mangabey simian immunodeficiency virus and human immunodeficiency virus type 2 nef alleles modulate cell surface expression of various human receptors and enhance viral infectivity and replication.
    Münch J; Schindler M; Wildum S; Rücker E; Bailer N; Knoop V; Novembre FJ; Kirchhoff F
    J Virol; 2005 Aug; 79(16):10547-60. PubMed ID: 16051847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monocyte/macrophage-derived CC chemokines and their modulation by HIV-1 and cytokines: a complex network of interactions influencing viral replication and AIDS pathogenesis.
    Fantuzzi L; Belardelli F; Gessani S
    J Leukoc Biol; 2003 Nov; 74(5):719-25. PubMed ID: 12960239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus pathogenesis and prospects for immune control in patients with established infection.
    Cohen DE; Walker BD
    Clin Infect Dis; 2001 Jun; 32(12):1756-68. PubMed ID: 11360218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maedi-visna virus and its relationship to human immunodeficiency virus.
    Thormar H
    AIDS Rev; 2005; 7(4):233-45. PubMed ID: 16425963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS.
    Brown CR; Czapiga M; Kabat J; Dang Q; Ourmanov I; Nishimura Y; Martin MA; Hirsch VM
    J Virol; 2007 Jun; 81(11):5594-606. PubMed ID: 17376901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host genetic factors that control immune responses to retrovirus infections.
    Miyazawa M; Tsuji-Kawahara S; Kanari Y
    Vaccine; 2008 Jun; 26(24):2981-96. PubMed ID: 18255203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-1 Tat protein: immunological facets of a transcriptional activator.
    Gupta S; Mitra D
    Indian J Biochem Biophys; 2007 Oct; 44(5):269-75. PubMed ID: 18341200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of HIV immune escape and reversion: implications for vaccination.
    Davenport MP; Loh L; Petravic J; Kent SJ
    Trends Microbiol; 2008 Dec; 16(12):561-6. PubMed ID: 18964018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 infection: is it time to reconsider our concepts?
    Krambovitis E; Spandidos DA
    Int J Mol Med; 2006 Jul; 18(1):3-8. PubMed ID: 16786149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of immune suppression in AIDS: possibilities of prevention.
    Gluckman JC; Klatzmann D
    Cancer Detect Prev; 1988; 12(1-6):175-80. PubMed ID: 3052831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of preserving HIV-specific immune responses.
    Kaufmann DE; Rosenberg ES
    J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.